{"id":591,"date":"2019-03-25T11:38:00","date_gmt":"2019-03-25T11:38:00","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/?p=591"},"modified":"2021-04-09T09:38:48","modified_gmt":"2021-04-09T09:38:48","slug":"press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/","title":{"rendered":"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"591\" class=\"elementor elementor-591\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6929209 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"6929209\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c425269\" data-id=\"c425269\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-266bdca elementor-widget elementor-widget-video\" data-id=\"266bdca\" data-element_type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/b7y8YHiqlNI&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0a92214 elementor-widget elementor-widget-text-editor\" data-id=\"0a92214\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"background-color: #ffffff; margin-top: 0px; margin-bottom: 22px; color: #3d2d2d; font-size: 18px; line-height: 26px;\"><em>\u201cFour months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office\u00a0<a style=\"text-decoration-line: underline;\" href=\"http:\/\/ast-innovations.com\/\">Aquitaine Science Transfert<\/a>\u00a0to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the\u00a0<a style=\"text-decoration-line: underline;\" href=\"https:\/\/enstbb.bordeaux-inp.fr\/fr\">ENSTBB<\/a>, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry with a solution to mass-produce stem cells, reducing costs and introducing an unprecedented quality standard. Protected by seven patents from the\u00a0<a style=\"text-decoration-line: underline;\" href=\"https:\/\/www.u-bordeaux.fr\/\">University of Bordeaux<\/a>,\u00a0<a style=\"text-decoration-line: underline;\" href=\"http:\/\/www.cnrs.fr\/\">CNRS<\/a>\u00a0and the\u00a0<a style=\"text-decoration-line: underline;\" href=\"https:\/\/www.institutoptique.fr\/\">Institut d\u2019Optique Graduate School<\/a>, TreeFrog\u2019s technology will enable millions of patients with degenerative diseases or waiting for organ transplantation, to access the medical revolution of<\/em><em>\u00a0cell therapies.\u201d<\/em><\/p><p style=\"background-color: #ffffff; margin-top: 0px; margin-bottom: 0px; color: #3d2d2d; font-size: 18px; line-height: 26px;\"><a style=\"text-decoration-line: underline;\" href=\"http:\/\/ast-innovations.com\/medias\/2019\/03\/COM-CP-20190325_Signature-licence-Treefrog_AST.pdf\">Read the Press Release<\/a>\u00a0(in French)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>https:\/\/youtu.be\/b7y8YHiqlNI \u201cFour months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office\u00a0Aquitaine Science Transfert\u00a0to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the\u00a0ENSTBB, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry&#8230;<\/p>\n","protected":false},"author":1,"featured_media":594,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[14,12,13,15],"tags":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"og:description\" content=\"https:\/\/youtu.be\/b7y8YHiqlNI \u201cFour months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office\u00a0Aquitaine Science Transfert\u00a0to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the\u00a0ENSTBB, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/\" \/>\n<meta property=\"og:site_name\" content=\"TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-25T11:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-09T09:38:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2021\/04\/TreeFrog-Therapeutics-licence-AST-SATT-Aquitaine.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Piergueritona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/\",\"name\":\"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\"},\"datePublished\":\"2019-03-25T11:38:00+00:00\",\"dateModified\":\"2021-04-09T09:38:48+00:00\",\"author\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\"},\"breadcrumb\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/preprod.treefrog.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\",\"url\":\"https:\/\/preprod.treefrog.fr\/\",\"name\":\"TreeFrog Therapeutics I iPS-derived cell therapies\",\"description\":\"Cell Therapy for All\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/preprod.treefrog.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\",\"name\":\"Piergueritona\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"caption\":\"Piergueritona\"},\"sameAs\":[\"https:\/\/preprod.treefrog.fr\"],\"url\":\"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies","og_description":"https:\/\/youtu.be\/b7y8YHiqlNI \u201cFour months after its creation, TreeFrog Therapeutic announces license agreement with tech transfer office\u00a0Aquitaine Science Transfert\u00a0to industrialize and commercialize a breakthrough technology based on 3D cell culture. Newly headquartered at the\u00a0ENSTBB, on the campus of Bordeaux, the start-up aims at providing the pharmaceutical industry...","og_url":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/","og_site_name":"TreeFrog Therapeutics I iPS-derived cell therapies","article_published_time":"2019-03-25T11:38:00+00:00","article_modified_time":"2021-04-09T09:38:48+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2021\/04\/TreeFrog-Therapeutics-licence-AST-SATT-Aquitaine.jpeg","type":"image\/jpeg"}],"author":"Piergueritona","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/","url":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/","name":"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert - TreeFrog Therapeutics I iPS-derived cell therapies","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/#website"},"datePublished":"2019-03-25T11:38:00+00:00","dateModified":"2021-04-09T09:38:48+00:00","author":{"@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220"},"breadcrumb":{"@id":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/preprod.treefrog.fr\/press-release-treefrog-therapeutics-signs-a-licence-agreement-with-tech-transfer-office-aquitaine-science-transfert\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/preprod.treefrog.fr\/"},{"@type":"ListItem","position":2,"name":"Press release : TreeFrog Therapeutics announces licence agreement with Aquitaine Science Transfert"}]},{"@type":"WebSite","@id":"https:\/\/preprod.treefrog.fr\/#website","url":"https:\/\/preprod.treefrog.fr\/","name":"TreeFrog Therapeutics I iPS-derived cell therapies","description":"Cell Therapy for All","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/preprod.treefrog.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220","name":"Piergueritona","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","caption":"Piergueritona"},"sameAs":["https:\/\/preprod.treefrog.fr"],"url":"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/"}]}},"_links":{"self":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/591"}],"collection":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/comments?post=591"}],"version-history":[{"count":0,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/591\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media\/594"}],"wp:attachment":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media?parent=591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/categories?post=591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/tags?post=591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}